“antibiotics” Archives

in
Entry Author Date Location
Otonomy Raises $49M to Advance 3 Drugs for Treating Ear Diseases 04/30/14 San Diego
Spero Emerges With $3M, Backing From Roche, & Plans to Disarm Bugs 04/09/14 Boston
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
Space Flight Launched Today Includes CU Studies of Antibiotics, Ants 01/09/14 Boulder/Denver
San Diego Life Sciences Roundup: Rempex, Pfenex, Halozyme & More 12/19/13 San Diego
Cubist Shares Climb As Antibiotic Scores in Phase 3 Again 12/16/13 Boston
Layoffs Hit Optimer Following Cubist Buyout 12/06/13 New York
San Diego’s Telephus Seeks $5M to Advance Anti-Infective Antibody 12/04/13 San Diego
Cubist’s Calixa Buyout Bears Fruit as Antibiotic Hits First Phase 3 Mark 11/25/13 Boston
Austin Startup Savara Wins Research Award for CF Therapy 10/17/13 Texas
San Diego Life Sciences News: Trius, Optimer, aTyr, Ligand, and More 08/01/13 San Diego
Cubist Adds Antibiotic Punch, Buys Trius and Optimer for $1.24B 07/30/13 Boston
Savara Enters the Proving Ground With Inhalable Antibiotic for CF 05/01/13 Texas
Enanta, Tetraphase Go Public in Boston Biotech IPO Madness 03/21/13 Boston
UCSD Business School’s Venture Fund Joins Texas Startup’s $16M Deal 03/20/13 San Diego
Optimer Board Ousts CEO, Brings Back Former Pfizer CEO McKinnell 02/27/13 San Diego
Cubist Grabs Option to Acquire Adynxx, Getting Drug for Pain 02/25/13 Boston
San Diego Life Sciences Roundup: RQx Pharma, Elcelyx, Lux, & More 02/15/13 San Diego
In VC ‘Hat Trick’ for San Diego’s Avalon, RQx Inks Genentech Deal 02/12/13 San Diego
East Coast Life Sciences Roundup: Ariad, Pfizer, Cubist, More 01/25/13 Boston
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Rib-X Closes First Tranche of $67.5 Million Preferred Stock Financing 11/29/12 Boston
With New Antibiotic in Hand, RQx Pharmaceuticals Looks for Partner 11/28/12 San Diego
San Diego Life Sciences Roundup: Tandem Diabetes, Santarus, & More 09/13/12 San Diego
In Search of Meaningful GAIN in Renewal of Prescription Drug Act 07/11/12 San Diego
San Diego Life Sciences Roundup: Amylin Buyout, PDUFA, & More 07/05/12 San Diego
Antibiotic R&D is in Trouble: Here’s One Way to Fix It 05/07/12 National
Cardeas Gears Up for Clinic, With Drug Combo for Hospital Infections 04/26/12 Seattle
Optimer Discloses Shakeup Prompted by Chairman’s Deal in Taiwan 04/09/12 National
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics 02/01/12 San Francisco
Page 2 of 6 « previous page · next page »